U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07852884) titled 'First-Line Systemic Therapies in Advanced Renal Cell Carcinoma in Spain' on Sept. 24.
Brief Summary: This retrospective observational study will use anonymized electronic medical records from the BIG-PAC(R) database to describe outcomes and treatment management for adults in Spain with advanced or metastatic renal cell carcinoma who start first-line systemic therapy.
Study Start Date: July 15
Study Type: OBSERVATIONAL
Condition:
Renal Cell Carcinoma (RCC)
Intervention:
DRUG: First-line systemic regimens
First-line systemic regimens for advanced or metastatic renal cell carcinoma include: nivolumab plus ipilimumab, axitinib plu...